Azithromycin (500 mg 20 ‐ 28 days) vs meglumine antimoniate (15 ‐ 20 mg/kg/d
Adverse effects · People with American cutaneous and mucocutaneous leishmaniasis
1 finding from 1 review
- Interventions for American cutaneous and mucocutaneous leishmaniasis 2020 · Cochrane Headline outcomes onlyno estimate extracted1 study · 45 participantsModerate